These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10209671)

  • 1. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease.
    Foy CJ; Passmore AP; Vahidassr MD; Young IS; Lawson JT
    QJM; 1999 Jan; 92(1):39-45. PubMed ID: 10209671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia.
    Polidori MC; Mattioli P; Aldred S; Cecchetti R; Stahl W; Griffiths H; Senin U; Sies H; Mecocci P
    Dement Geriatr Cogn Disord; 2004; 18(3-4):265-70. PubMed ID: 15286458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease.
    Aldred S; Bennett S; Mecocci P
    Clin Biochem; 2010 Feb; 43(3):267-71. PubMed ID: 19733555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia.
    Sinclair AJ; Bayer AJ; Johnston J; Warner C; Maxwell SR
    Int J Geriatr Psychiatry; 1998 Dec; 13(12):840-5. PubMed ID: 9884908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients.
    Serra JA; Domínguez RO; de Lustig ES; Guareschi EM; Famulari AL; Bartolomé EL; Marschoff ER
    J Neural Transm (Vienna); 2001; 108(10):1135-48. PubMed ID: 11725816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test.
    Allone C; Lo Buono V; Corallo F; Bonanno L; Palmeri R; Di Lorenzo G; Marra A; Bramanti P; Marino S
    Psychogeriatrics; 2018 Mar; 18(2):123-131. PubMed ID: 29417704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma antioxidant activity and vascular dementia.
    Ryglewicz D; Rodo M; Kunicki PK; Bednarska-Makaruk M; Graban A; Lojkowska W; Wehr H
    J Neurol Sci; 2002 Nov; 203-204():195-7. PubMed ID: 12417383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamins, trace elements, and antioxidant status in dementia disorders.
    Tabet N; Mantle D; Walker Z; Orrell M
    Int Psychogeriatr; 2001 Sep; 13(3):265-75. PubMed ID: 11768374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease.
    Mecocci P; Polidori MC; Cherubini A; Ingegni T; Mattioli P; Catani M; Rinaldi P; Cecchetti R; Stahl W; Senin U; Beal MF
    Arch Neurol; 2002 May; 59(5):794-8. PubMed ID: 12020262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance.
    Li L; Willets RS; Polidori MC; Stahl W; Nelles G; Sies H; Griffiths HR
    Free Radic Res; 2010 Mar; 44(3):241-8. PubMed ID: 20166891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
    Allan LM; Ballard CG; Burn DJ; Kenny RA
    J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of vascular comorbidities on the antioxidant defense system in Alzheimer's disease].
    Polidori MC; Stahl W; De Spirt S; Pientka L
    Dtsch Med Wochenschr; 2012 Feb; 137(7):305-8. PubMed ID: 22318842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine, antioxidant vitamins and lipids as biomarkers of neurodegeneration in Alzheimer's disease versus non-Alzheimer's dementia.
    Raszewski G; Chwedorowicz R; Chwedorowicz A; Gustaw Rothenberg K
    Ann Agric Environ Med; 2016; 23(1):193-6. PubMed ID: 27007541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases.
    Sofic E; Sapcanin A; Tahirovic I; Gavrankapetanovic I; Jellinger K; Reynolds GP; Tatschner T; Riederer P
    J Neural Transm Suppl; 2006; (71):39-43. PubMed ID: 17447414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities and differences between Alzheimer's disease and vascular dementia from the viewpoint of nutrition.
    Otsuka M; Yamaguchi K; Ueki A
    Ann N Y Acad Sci; 2002 Nov; 977():155-61. PubMed ID: 12480746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease.
    Polidori MC; Mecocci P
    J Alzheimers Dis; 2002 Dec; 4(6):517-22. PubMed ID: 12629261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.
    Pimlott SL; Piggott M; Owens J; Greally E; Court JA; Jaros E; Perry RH; Perry EK; Wyper D
    Neuropsychopharmacology; 2004 Jan; 29(1):108-16. PubMed ID: 12955099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
    Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
    Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.
    Moon Y; Han SH; Moon WJ
    J Alzheimers Dis; 2016; 51(3):737-45. PubMed ID: 26890777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
    Paragh G; Balla P; Katona E; Seres I; Egerházi A; Degrell I
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):63-7. PubMed ID: 12111338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.